SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 8:47 pm Purchase | 2025-06-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 6,488,324 7.700% | 710,136 (+12.29%) | Filing |
| 2024-02-13 12:16 pm Purchase | 2023-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,778,188 9.500% | 213,089 (+3.83%) | Filing |
| 2023-02-13 10:56 am Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,565,099 9.700% | 3,091,304 (+124.96%) | Filing |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,473,795 5.400% | 65,400 (+2.72%) | Filing |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,408,395 5.200% | 2,408,395 (New Position) | Filing |